A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

Carboplatin (AUC4.5) Gemcitabine

Description
Chemotherapy Protocol BLADDER CARBOPLATIN (AUC4.5)-GEMCITABINE Regimen  Bladder-Carboplatin-Gemcitabine Indication  Locally advanced or metastatic urothelial cancer  WHO performance status
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Carboplatin-AUC4.5-Gemcitabine.pdf

HSCT AmB Melphalan

Description
Chemotherapy Protocol HAEMATOLOGY – HSCT AUTOGRAFT AMBULATORY MELPHALAN (200mg/m2) Multiple Myeloma This regimen will only be available to prescribe at units
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/HSCT-AmB-Melphalan.pdf

Carboplatin (AUC6) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat Regimen (AUC6) • Ovary – Carboplatin (AUC6) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC6Retreat.pdf

Carboplatin-Vinorelbine-IV-RT

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN-VINORELBINE-RADIOTHERAPY (Intravenous) Regimen • NSCLC – Carboplatin-Vinorelbine (intravenous)-Radiotherapy Indication • First line
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Vinorelbine-IV-RT.pdf

Dacomitinib

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) DACOMITINIB Regimen • NSCLC - Dacomitinib Indication Dacomitinib for untreated EGFR-positive non-small-cell
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Dacomitinib.pdf

Carboplatin (AUC5)-Pegylated Liposomal Doxorubicin (Caelyx)x)

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) - DOXORUBICIN PEGYLATED LIPOSOMAL (Caelyx) Please note this protocol is based on information for the use
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Pegylated-Liposomal-DoxorubicinCaelyxVer1.pdf

Carboplatin(AUC5)Etoposide

Description
Regimen Chemotherapy Protocol BRAIN TUMOURS CARBOPLATIN (AUC5)-ETOPOSIDE • Brain – Carboplatin (AUC5)-Etoposide Indication • Third line treatment of glioblastoma multiforme • WHO Performance
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/CarboplatinAUC5-Etoposide.pdf

Carboplatin (AUC5) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat (AUC5) Regimen • Ovary – Carboplatin (AUC5) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Retreat.pdf

Carboplatin (AUC4)-Gemcitabine (day 1, 8) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1, 8) Retreat Regimen • Ovary-Carboplatin (AUC4)-Gemcitabine (1, 8) Retreat Indication • Recurrent
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabineday18Retreat.pdf

Azathioprine to treat neurological diseases - patient information

Description
This factsheet contains information about the use of azathioprine to treat neurological diseases, including how the treatment is given and the
Url
/Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Azathioprine-to-treat-neurological-diseases-3153-PIL.pdf
661 to 670 of 1000
Previous … 65 66 67 68 69 … Next